康沣生物2024年收入及毛利稳步增加 持续坚定研发投入
Apr 01, 2025 00:30 HKT | |
|
康灃生物2024年收入及毛利穩步增加 持續堅定研發投入
Apr 01, 2025 00:17 HKT | |
|
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025
Mar 31, 2025 11:00 HKT |  |
|
China Medical System (00867) Released its 2024 Annual Results: Focusing on Innovation and Specialty Breakthroughs to Reshape Growth Momentum
Mar 21, 2025 23:00 HKT |  |
|
Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson's Disease
Mar 16, 2025 01:30 HKT |  |
|
Giftify, Inc. Announces Smart Savings Solution for Popular GLP-1 Diabetes and Weight Loss Medications
Feb 21, 2025 08:00 HKT |  |
|
China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025
Feb 14, 2025 20:00 HKT | |
|
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10
Jan 24, 2025 23:00 HKT | |
|
China Medical System (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type
Jan 09, 2025 08:00 HKT | |
|
World's first high-standard negative-pressure isolation ward built with MiC technology completes historical mission
Dec 30, 2024 20:04 HKT | |
|
全球首个组装合成可快速建造高规格负压隔离病房完成历史任务
Dec 30, 2024 18:10 HKT | |
|
全球首個組裝合成可快速建造高規格負壓隔離病房完成歷史任務
Dec 30, 2024 17:43 HKT | |
|
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China
Dec 09, 2024 13:00 HKT | |
|
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia
Dec 02, 2024 21:30 HKT | |
|
康哲藥業獲得治療痛風及高尿酸血症的1類新藥獨家商業化權利
Dec 02, 2024 20:49 HKT | |
|
康哲药业获得治疗痛风及高尿酸血症的1类新药独家商业化权利
Dec 02, 2024 20:37 HKT | |
|
愛康醫療三度榮膺北京市科技一等獎 推動髖關節發育不良診療技術革新
Nov 20, 2024 19:35 HKT | |
|
爱康医疗三度荣膺北京市科技一等奖 推动髋关节发育不良诊疗技术革新
Nov 20, 2024 19:12 HKT | |
|
康哲药业入选2024年度“中国医药上市公司ESG竞争力”系列榜单
Oct 21, 2024 19:15 HKT | |
|
China Medical System: First Ruxolitinib Cream's Prescriptions for Vitiligo Issued in the Greater Bay Area
Oct 21, 2024 10:00 HKT | |
|
|
Next >>
|